This year’s International Parkinson and Movement Disorder Society (MDS) was held over the last weekend of September in Philadelphia. The theme, “Movement Disorders in the Digital Age: Harnessing AI for...
Read More
We were privileged to attend the 7th Annual Digital Biomarkers in Clinical Trials Summit at the Roche Headquarters in Basel on June 26th, 2024. Over 300 attendees attended the consortium,...
Read More
Last week, two important events happened, both hosted by the Critical Path Institute (C-Path): the Electronic Clinical Outcome Assessment (eCOA) Consortium meeting on April 16, and the 2024 Clinical Outcome...
Read More
The American Society for Clinical Pharmacology & Therapeutics(ASCPT) hosted a Patient Forum on March 28 at the 2024 annual meeting. I was privileged to chair the discussion, which centered on...
Read More
The Mobilise-D Consortium gathered in Edinburgh, Scotland on March 20, 2024 for an end-of-project conference, which turned into a day of celebration of science. The idea of putting together efforts...
Read More
The recent Alzheimer’s and Parkinson’s Disease Conference (ADPD) demonstrated that it is an exciting time for drug development in Parkinson’s disease. Parkinson’s disease is being redefined by alpha synuclein biology,…
“Rare” diseases are something of a misnomer: about 30 million Americans, half of them children, have a rare disease – and 90% have no approved treatments at all. The need…
The balance of healthcare innovation lies in developing new treatments, while also ensuring that everyone has access and nobody is left behind. At Koneksa, our team has been busy pushing...
Read More
Koneksa recently participated in two milestone gatherings in the digital health community. Let’s talk about what they were and why they matter! The first was the first meeting of the…
At the recent CNS Summit – an annual gathering of R&D life science leaders that has taken place since 2009 – Koneksa was proud to sit down with some of…
